Crystallin beta A1 (CRYBA1)

Crystallin beta A1 (CRYBA1) is a structural protein highly expressed in the vertebrate eye lens, where it plays a key role in maintaining lens transparency and refractive index by forming stable hetero- and homodimers with other crystallins and contributing to the precise organization of lens fibers[1][4][5]. It is encoded by the *CRYBA1* gene, which produces two isoforms, beta A3 and beta A1, via alternative translation initiation from a single mRNA transcript[1][5]. Beyond its primary role as a lens protein, CRYBA1 is also expressed in retinal pigment epithelial cells, retinal astrocytes, and retinal ganglion cells, where it acts as a lysosomal protein regulating autophagy and lysosomal pH, and is involved in modulation of glucose metabolism via interaction with protein tyrosine phosphatase 1B (PTP1B)[2][3][4]. Mutations or deletions in the *CRYBA1* gene are associated with congenital and early-onset cataracts, typically through loss of protein stability and subsequent lens opacification[1][4][5]. No evidence was identified supporting CRYBA1 as a direct drug target, therapeutic target, or receptor.[1][4][5] No approved drugs are known to specifically target this protein, and it is not classified as a classical receptor, enzyme, transporter, or transcription factor. Its clinical interest centers on genetic diagnosis and understanding cataract pathophysiology.

Other names

Crystallin beta A3Beta-crystallin A3Beta-crystallin A3, isoform A1, Delta4 formBeta-crystallin A3, isoform A1, Delta7 formBeta-crystallin A3, isoform A1, Delta8 formBeta-crystallin A3, isoform A1Eye lens structural proteinCRYB1CTRCT10Crystallin beta A3/A1Crystallin, beta A3Beta crystallin A3 chain transcript CNBeta crystallin A3 chain transcript LAMBeta crystallin A3 chain transcript PSBeta crystallin A3 chain transcript TC